A new trading day began on Monday, with Recursion Pharmaceuticals Inc (NASDAQ: RXRX) stock price up 4.05% from the previous day of trading, before settling in for the closing price of $4.2. RXRX’s price has ranged from $3.79 to $12.36 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -35.28%. Meanwhile, its annual earnings per share averaged 6.97%. With a float of $437.67 million, this company’s outstanding shares have now reached $485.21 million.
Recursion Pharmaceuticals Inc (RXRX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Recursion Pharmaceuticals Inc is 15.91%, while institutional ownership is 48.91%. The most recent insider transaction that took place on Jan 05 ’26, was worth 170,000. Before that another transaction happened on Dec 29 ’25, when Company’s Chief Financial Officer sold 21,383 for $4.18, making the entire transaction worth $89,381. This insider now owns 761,550 shares in total.
Recursion Pharmaceuticals Inc (RXRX) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.53 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.97% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.69% during the next five years compared to -35.28% drop over the previous five years of trading.
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Trading Performance Indicators
Here are Recursion Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 52.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.81, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.16 in one year’s time.
Technical Analysis of Recursion Pharmaceuticals Inc (RXRX)
The latest stats from [Recursion Pharmaceuticals Inc, RXRX] show that its last 5-days average volume of 18.33 million was superior to 16.92 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 34.10%.
During the past 100 days, Recursion Pharmaceuticals Inc’s (RXRX) raw stochastic average was set at 16.62%, which indicates a significant decrease from 33.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was lower than the 0.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.65, while its 200-day Moving Average is $5.08. Now, the first resistance to watch is $4.44. This is followed by the second major resistance level at $4.52. The third major resistance level sits at $4.61. If the price goes on to break the first support level at $4.27, it is likely to go to the next support level at $4.18. The third support level lies at $4.10 if the price breaches the second support level.
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Key Stats
With a market capitalization of 2.27 billion, the company has a total of 519,838K Shares Outstanding. Currently, annual sales are 58,840 K while annual income is -463,660 K. The company’s previous quarter sales were 5,180 K while its latest quarter income was -162,250 K.
